Probiotic bacteria express a wide range of molecular structures that bind to receptors on innate immune cells and mediate healthpromoting effects in the host. We have recently demonstrated in a colitis model that favourable effects of the probiotic mixture VSL#3 may in part be due to the suppression of intestinal chemokine expression. To obtain more insights into the underlying mechanisms, in the present study, we analysed the modulation of bone marrow-derived dendritic cells (BM-DC) from BALB/c (T helper (Th)2 biased) v. C57BL/6 (Th1 biased) mice. Our findings showed that VSL#3 differed from pure Toll-like receptor (TLR) ligands by inducing the production of various cytokines, including IL-12 p70 subunit (IL-12p70), IL-23 and IL-10. Dedicated TLR arrays were employed to profile mRNA from BM-DC cultured with lipopolysaccharide (LPS), VSL#3, or a combination of both. This approach led to the identification of (1) a cluster of genes that were up-or down-regulated, irrespective of the stimulus, (2) a cluster of genes that were synergistically up-regulated by LPS and VSL#3 in BM-DC from C57BL/6 mice, but not in those from BALB/c mice, and (3) a cluster of LPS-induced genes that were suppressed by VSL#3, in particular chemokine genes. These data show that this probiotic mixture has both pro-and anti-inflammatory effects on BM-DC and suggest that their immune-modulating properties in vivo may depend on the genetic background of the host.
understanding of the mechanism by which micro-organisms modulate immune responses in vivo. Although not identical to intestinal DC, it has been demonstrated that splenic DC from Th1-prone C57BL/6 mice and Th2-prone BALB/c mice respond differently to microbial stimuli (5 -7) , and this may in part be explained by differences in the expression of TLR. BALB/c mice express higher levels of Tlr2, Tlr4 and Tlr5 mRNA, whereas C57BL/6 mice express higher levels of Tlr9 mRNA (8) . In addition, the expression of the macrophage mannose receptor on BM-DC is mouse-strain specific, and this phenomenon may influence antigen uptake by such cells (9) .
Probiotic bacteria modulate DC via surface expression and/or secretion of products that function as ligands for TLR and C-type lectin receptors. The expression of these ligands depends on bacterial species, growth phases and available nutrients, and this explains in part why different species and strains of probiotics vary in their ability to induce cytokines and chemokines (10 -12) .
We have recently demonstrated that treatment of BALB/c mice with a mixture of probiotic bacteria (i.e. VSL#3) has profound effects on gene expression in the colon of mice subjected to colitis induction, with favourable effects on the development of disease (13) . However, substantial variability in the response of human subjects to probiotic interventions has been found (14) , suggestive of an influence of genetic and environmental factors.
To gain more insights into the influence of genetic background, in the present study, we examined BM-DC from two genetically distinct mouse strains and evaluated their responses to the probiotic mixture VSL#3 in vitro compared with those to ultrapure TLR ligands. The results of the present study, obtained by dedicated gene expression profiling of genes related to TLR signalling and by studying cytokine production, indicate that VSL#3 may display both pro-and anti-inflammatory effects, dependent on the mouse strain.
Materials and methods
Mice C57BL/6 mice (Charles River Laboratories) and BALB/c mice ( Janvier) aged 7 -11 weeks were used in the present study. All animal experiments were conducted with the approval of the Institutional Animal Welfare Committee, filed as no. DEC2661, in compliance with European Community specifications regarding the use of laboratory animals.
Isolation and culture of bone marrow-derived dendritic cells
BM-DC were isolated as described previously (15) , with slight modifications. Briefly, bone marrow was flushed from femur and tibia. Cells were passed through nylon mesh to obtain a single cell suspension. After a single wash step, cells were cultured in Roswell Park Memorial Institute medium 1640 containing 10 % fetal bovine serum (Lonza), 2 mM -L-glutamine, 100 U/ml streptomycin, 100 mg/ml penicillin (Gibco) and 50 mM -b-mercaptoethanol (Sigma-Aldrich) in the presence of 20 ng/ml of recombinant mouse granulocyte-macrophage colony-stimulating factor (PeproTech, Inc.). Cells were cultured (10 6 cells/ml) at 378C. On days 3 and 6 of culture, twothirds of the medium were refreshed. After 8 d of culture, nonadherent and loosely adherent BM-DC were collected and used for stimulation experiments. The viability of cells (.95 %) was assessed by trypan blue dye exclusion. Cells were cultured at a density of 10 6 /ml and stimulated with TLR ligands and/or probiotic bacteria at concentrations indicated in the figure legends. lactis BB-82 were grown at 378C in Man-Rogosa -Sharpe broth (Scharlau Chemie) until mid-exponential density (OD 600 nm ¼ 1). Bacterial cells were washed twice with PBS (pH 7·4). Lyophilised bacteria were prepared by freezing bacterial pellets (2808C) before overnight lyophilisation in a freeze dryer under vacuum (40 mbar). Lyophilised bacteria were stored at 2 208C until use.
Reagents

RNA isolation and real-time quantitative PCR
Total RNA was isolated from 10 6 cells using an RNeasy Kit (Qiagen) according to the manufacturer's instructions. RNA (500 ng) was reverse-transcribed into single-stranded complementary DNA using the High-Capacity RNA-to-cDNA Kit (Applied Biosystems) and incubated for 60 min at 378C and 5 min at 958C. Complementary DNA was amplified employing a 7500 Fast thermal cycler (Applied Biosystems) using SYBR Green PCR Master Mix (Applied Biosystems). Thermal cycling parameters consisted of 1 min at 508C and 10 min at 958C, followed by forty cycles of 15 s at 958C and 1 min at 608C. The following primer pairs were used: IL-12 p35 subunit (Il12p35) -5 0 -CTG GAG CAT CCG AAT TGC A-3 0 (sense) and 5 0 -CAT CCT CTG AGA TTT GAC GCT TT-3 0 (anti-sense); IL-23 p19 subunit (Il23p19) -5 0 -GGC AAC TTG GAC CTG AGG AG-3 0 (sense) and 5 0 -CAT GGG CTC TCG GTC CAT AG-3 0 (anti-sense); chemokine (C-X-C motif ) ligand 9 (Cxcl9) -5 0 -CCT AGT GAT AAG GAA TGC ACG ATG-3 0 (sense) and 5 0 -CTA GGC AGG TTT GAT CTC CGT TC-3 0 (anti-sense); Chemokine (C-X-C motif) ligand 10 (Cxcl10) -5 0 -ATC ATC CCT GCG AGC CTA TCC T-3 0 (sense) and 5 0 -GAC CTT TTT TGG CTA AAC GCT TTC-3 0 (anti-sense); b-2-microglobulin (B2m) -5 0 -ACC GTG AAA AGA TGA TGA CCC AG-3 0 (sense) and 5 0 -AGC CTG GAT GGC TAC GTA CA-3 0 (anti-sense); IL-12 p40 subunit (Il12p40) -5 0 -GGA AGC ACG GCA GCA GAA TA-3 0 (sense) and 5 0 -AAC TTG AGG GAG AAG TAG GAA TGG-3 0 (anti-sense). Gene expression levels were quantified according to the following formula: 2 2ðCti2CtaÞ , where C ti is the cycle threshold value of the gene of interest and C ta is the cycle threshold value of b-actin.
PCR array analysis
The expression of genes involved in TLR pathways was studied using the RT 2 -Profiler PCR Array (mouse TLR signalling pathway) obtained from SABiosciences. This array combines the quantitative performance of SYBR Green-based real-time PCR with the multiple gene profiling capabilities of a microarray. In this analysis, ninety-six-well plates containing genespecific primer sets for eighty-four relevant TLR pathway genes, five housekeeping genes and two negative controls were used. For each experimental condition, RNA was isolated as described above. Gene expression was normalised to internal controls (housekeeping genes) to determine the fold change in gene expression between test and control samples by DDC t (SABioscience).
Cytokine/chemokine analysis
Cytokines present in the supernatants of BM-DC cultures were quantified 24 h after cell stimulation using commercially available ELISA kits for IL-12 p70 subunit (IL-12p70), IL-12p40, IL-23, IL-10, IL-6 and TNFa (eBioscience). Chemokines (CXCL-9 and CXCL-10) were quantified using a multiplex immunoassay (Invitrogen). Assays were carried out according to the manufacturer's instructions.
Flow cytometric analyses
BM-DC were phenotypically characterised before and after 24 h of stimulation. Cells were collected and washed with PBS. Later, 2 £ 10 5 cells were incubated (30 min, 48C, protected from light) with monoclonal antibodies. The following dye-conjugated antibodies were purchased from BD Biosciences: CD11c-PerCP/Cy5.5 (N418); CD86-FITC (B7-2GL-1); CD80-Pacific Blue (16-10A1); major histocompatibility complex-phycoerythrin (MHCII-PE) (M5/114.15.2); CD317-allophycocyanin (APC) (927); CD103-PE (2E7). Flow cytometric analyses were carried out using a fluorescence-activated cell sorter (FACSCanto II; BD Biosciences) and FACSDiva software 6.1.2 (BD Biosciences). Gating of positive cells was based on the results obtained with isotype control antibodies.
Statistical analyses
Statistical analyses were carried out using the Mann-Whitney U test or Student's t test if the samples passed the normality tests using RT 2 Profilere PCR Array Data Analysis (SABiosciences).
Results
Bone marrow progenitors from BALB/c and C57BL/6 mice differentiate into phenotypically distinct dendritic cells BM-DC from BALB/c and C57BL/6 mice were generated by 8 d of culture under identical conditions in the presence of granulocyte-macrophage colony-stimulating factor. As shown in Fig. 1 expression of Tlr3 and interferon (Ifn)b in BM-DC from BALB/c mice ( Fig. 1(e) ). BM-DC from BALB/c mice also exhibited significantly higher levels of Tlr5, Tlr6 and Tlr9 mRNA when compared with BM-DC from C57BL/6 mice ( Fig. 1(f) ). Before studying the response of these cells to probiotic bacteria, we evaluated their response to ultrapure TLR ligands. Flow cytometric analysis of the stimulated BM-DC confirmed a similar up-regulation of CD80, CD86 and MHC class II expression, regardless of the mouse strain or TLR ligand (data not shown). However, BM-DC from BALB/c and C57BL/6 mice exhibited a different cytokine response to several TLR ligands, as shown in Fig. S1 (available online) . In particular, the production of IL-12p70 in response to LPS or CpG was higher in BM-DC from C57BL/6 mice. These data indicate that the genetic background strongly influences the phenotype and response of BM-DC to pure TLR ligands. Fig. 3 . Differences in gene expression between bone marrow-derived dendritic cells (BM-DC) from C57BL/6 mice and those from BALB/c mice. The supervised hierarchical clustering of genes related to Toll-like receptor signalling after stimulation of BM-DC with medium, lipopolysaccharide (LPS; 1 mg/ml), VSL#3 (10 7 colony-forming units/ml), or a combination of both is shown by the clusterogram. Relative expression levels for each individual gene are shown as minimum (green) and maximum (red). Columns represent the gene expression profiles of BM-DC from C57BL/6 and BALB/c mice after stimulation for 4 h (three individual mice per strain and experimental condition). For the description of gene symbols, see Table 1 . ---, Unstimulated cells.
C57BL/6 BALB/c
The probiotic mixture VSL#3 and lipopolysaccharide synergistically induce IL-12p70 and IL-23 production in bone marrow-derived dendritic cells from C57BL/6mice
Probiotic bacteria are far more complex than ultrapure TLR ligands and therefore we investigated to what extent the genetic background of BM-DC would influence their response to VSL#3. We stimulated BM-DC with increasing numbers of bacteria, in the absence or presence of LPS. In Fig. 2(a) -(c), the production of TNFa, IL-6 and IL-12p70 upon stimulation of BM-DC from C57BL/6 mice is shown. The production of all these cytokines was stimulated by VSL#3 in a dose-dependent manner. Simultaneously, VSL#3 strongly induced the production of IL-10 ( Fig. S1 , available online). The combination of VSL#3 and LPS exerted an additive effect on the production of all these cytokines. However, at a VSL#3:DC ratio of 10:1, a synergistic induction of IL-12p70 production was observed.
BM-DC from C57BL/6 mice exhibited a synergistic increase in IL-12p70 and IL-23 production in response to VSL#3 and LPS, whereas such an effect was not observed in BM-DC from BALB/c mice ( Fig. 2(d) and (e)). This difference in the response of BM-DC from C57BL/6 and BALB/c mice was confirmed for IL-12p70 with L. plantarum, one of the constituents of VSL#3 (Fig. 2(d) and (e)).
Recently, it has been shown that TIR-domain-containing adapter-inducing interferon-b (TRIF)-and myeloid differentiation primary response gene (88) (MyD88)-dependent TLR ligands act in synergy to induce the release of IL-12p70 in BM-DC (16) . However, VSL#3 did not exhibit synergy with the MyD88-coupled TLR ligands CpG and Pam 3 CSK 4 or the TRIF-coupled TLR ligand poly I:C with regard to the induction of Il12p35 and Il23p19 mRNA expression ( Fig. 2(f) and (g) ).
Synergy in the induction of IL-12p70 and IL-23 production was hence specific for the combination of VSL#3 and LPS and was only observed in BM-DC from C57BL/6 mice. Colony stimulating factor 2 (granulocyte-macrophage) Csf3
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TLR gene array analysis of bone marrow-derived dendritic cells identifies the stimulating and blocking activities of VSL#3
To identify mechanisms by which probiotic bacteria may modulate the innate immune response, we analysed the mRNA expression of eighty-four genes involved in TLR signalling. A time course study revealed a peak in the levels of Il12p35, Il12p40 and Il23p19 mRNA after 4 h of stimulation with VSL#3 and LPS (data not shown). Therefore, RNA was isolated from BM-DC after 4 h of culture with or without LPS, VSL#3, or a combination of both. In Fig. 3 , the relative gene expression in BM-DC from C57BL/6 and BALB/c mice is shown. Results obtained for three individual mice per stimulus are each shown as a column in this heat map. Hierarchical clustering of transcripts in BM-DC from C57BL/6 mice revealed genes that are co-regulated. In BM-DC from both mouse strains, LPS and VSL#3 down-regulated a cluster of genes encoding TLR, e.g. Tlr5, Tlr4 and Tlr8. Moreover, both VSL#3 and LPS induced a set of pro-inflammatory gene transcripts, such as Tnf, Il1a and Il6, regardless of the mouse strain.
In addition to the synergistic induction of IL-12 and IL-23 production ( Fig. 2(d) -(g) ), the TLR signalling array revealed that the combination of VSL#3 and LPS synergistically induced the expression of several other genes involved in innate immunity. In Fig. 4 , the three representatives of this cluster -lymphotoxin A (Lta), Ifng and Ifnb -that were synergistically induced in BM-DC from C57BL/6 mice, but not in BM-DC from BALB/c mice, are shown.
Importantly, a set of LPS-induced gene transcripts was suppressed by VSL#3 in BM-DC from both BALB/c and C57BL/6 mice. Myd88, Cxcl9 and Cxcl10 were the most important representatives of this cluster.
The suppressive effect of VSL#3 on LPS-induced Cxcl9 and Cxcl10 expression was verified by quantitative real-time PCR ( Fig. 5(a) and (b) ). Down-regulation was also confirmed from the protein levels of CXCL-10 ( Fig. 5(c) ): levels of CXCL-9 were below the detection limit.
VSL#3 is composed of different members of two lactic acid genera, i.e. lactobacilli and bifidobacteria. Therefore, we studied the effects of representative members, i.e. L. plantarum and Bifidobacterium lactis. Whereas L. plantarum suppressed LPS-induced CXCL-10 expression at both the mRNA and protein levels and Cxcl9 expression at the mRNA level, B. lactis failed in this respect ( Fig. 5(d) and (e)).
Discussion
Probiotic bacteria and prebiotic supplements have successfully been used in the treatment of various inflammatory disorders, including allergies and intestinal disorders (17, 18) . However, results of clinical trials are not consistent and variation in efficacy most probably depends on numerous factors, including bacterial strain type (single strain v. a mixture of strains), dosing regimen, delivery method and host factors, such as genetics, age, diet and disease state (19) . Several trials have shown the beneficial effects of lactobacilli, bifidobacteria and E. coli Nissle 1917 on the induction of remission as well as the maintenance of remission in patients with ulcerative colitis (20) . However, the efficacy in Crohn's disease appears less evident (21) . In the present study, we employed a simplified model system to evaluate the effects of VSL#3 -a complex mixture of TLR ligands -on BM-DC and identified both pro-and antiinflammatory effects. These apparently contradictory findings may be due to the simultaneous presence of eight probiotic strains. On the other hand, similar contradictory effects were observed with L. plantarum, i.e. one single probiotic strain. In fact, even individual TLR ligands may induce a quick and transient production of pro-inflammatory cytokines such as IL-12, followed by the production of anti-inflammatory cytokines such as IL-10, as part of a suppressive mechanism essential for limiting the extent of inflammation. The balance between (the levels) of these cytokines may differ between individuals and represents a major determinant for the severity of the subsequent inflammation process. Besides, probiotic bacteria may mediate additional mechanisms in vivo that control the severity of inflammation, e.g. enhancement of intestinal barrier function, alteration of epithelial signalling, competition with pathogens, and secretion of SCFA such as acetate, propionate and butyrate, and also exert effects on immune cells distinct from DC (22 -26) .
Although we allowed bone marrow progenitors from BALB/c v. C57BL/6 mice to differentiate in vitro into immature DC under controlled and identical conditions, we observed that VSL#3 and several TLR ligands induced a more pronounced pro-inflammatory response in cells from C57BL/6 mice, whereas those from BALB/c mice exhibited more IL-10 production. These observations are consistent with differences between the two mouse strains in terms of cellular and humoral immune responses to different pathogens (27 -29) . No explanations for these differences could be obtained from the levels of Tlr gene expression in the present study. Moreover, we observed that VSL#3 augmented the induction of IL-12p70 and IL-23 production by LPS in a synergistic fashion in BM-DC from C57BL/6 mice, but not in those from BALB/c mice. Furthermore, several other genes involved in cellular immunity were synergistically up-regulated after combined stimulation with VSL#3 and LPS. This indicates that this mixture of probiotic bacteria has the potential to amplify inflammatory responses dependent on the genetic background of the host. In parallel studies employing human DC, we demonstrated that LPS-induced phosphorylation of transducers and activators of transcription 1 (STAT-1) was inhibited by VSL#3, whereas phosphorylation of NF-kB was not affected (R Mariman and L Nagelkerken, unpublished results). A similar mechanism could explain the inhibition of secretion of chemokines, such as CXCL-9 and CXCL-10, by VSL#3, along with a robust induction of IL-12 and IL-23 production.
It should be noted that the effects of VSL#3 are not representative for individual probiotic strains, as has been shown by comparing L. plantarum and B. lactis in our in vitro studies.
Differential immune-modulating capacities of specific probiotic bacterial species in vivo are likely to be caused by the distinct repertoire of microbe-associated molecular patterns or effector molecules, which are expressed in a strain-specific manner (30) .
Our findings also indicate that certain probiotic strains may be ineffective in vivo or may even display adverse effects during ongoing inflammation (31, 32) . On the other hand, our extensive characterisation of gene expression during the induction of trinitrobenzene sulphonic acid colitis in BALB/c mice did not reveal that VSL#3 increased Il12p40 or Il23p19 mRNA levels in colonic tissue (not even in the acute phases of the model) (33) . As has been mentioned above, this might be due to simultaneous induction of anti-inflammatory cytokine production and dampening of the local inflammatory response through mechanisms distinct from TLR signalling.
Importantly, in this in vitro study, we confirmed that probiotic bacteria may down-regulate the production of chemokines in agreement with our in vivo findings in the recurrent trinitrobenzene sulphonic acid colitis model, where we also showed less recruitment of inflammatory cells and a lower disease severity (33) .
Altogether, our data indicate that the net effect of probiotic bacteria in vivo depends on a complex of factors that vary between individuals and may depend on their genetic background and health status.
